v3.26.1
Condensed Consolidated Statements of Stockholders’ Equity (Unaudited) - USD ($)
Preferred Stock
Common Stock
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Capital Reserve
Accumulated Deficit
Total
Balance at Dec. 31, 2024 $ 1 $ 17,157 $ (749,625) $ 56,952,200 $ 899,917 $ (43,662,547) $ 13,457,103
Balance (in Shares) at Dec. 31, 2024 1,000 171,579,284          
Stock-based compensation 2,110,467 2,110,467
Common stock issued against exercise of warrants (in Shares) 10,477          
Conversion of notes payable to equity (in Shares) 21,966,416          
Net loss 22,714 (5,681,353) (5,658,639)
Balance at Mar. 31, 2025 $ 1 $ 19,354 (726,911) 89,705,829 899,917 (49,343,900) 40,554,290
Balance (in Shares) at Mar. 31, 2025 1,000 193,556,177          
Balance at Dec. 31, 2024 $ 1 $ 17,157 (749,625) 56,952,200 899,917 (43,662,547) 13,457,103
Balance (in Shares) at Dec. 31, 2024 1,000 171,579,284          
Net loss             (6,011,232)
Balance at Jun. 30, 2025 $ 1 $ 19,357 (822,813) 91,526,999 899,917 (49,600,591) 42,022,870
Balance (in Shares) at Jun. 30, 2025 1,000 193,588,410          
Balance at Mar. 31, 2025 $ 1 $ 19,354 (726,911) 89,705,829 899,917 (49,343,900) 40,554,290
Balance (in Shares) at Mar. 31, 2025 1,000 193,556,177          
Stock-based compensation 1,579,376 1,579,376
Stock issued for services $ 2 241,795 241,797
Stock issued for services (in Shares) 24,802          
Common stock issued against exercise of warrants $ 1 (1)
Common stock issued against exercise of warrants (in Shares) 7,431          
Net loss (95,902) (256,691) (352,593)
Balance at Jun. 30, 2025 $ 1 $ 19,357 (822,813) 91,526,999 899,917 (49,600,591) 42,022,870
Balance (in Shares) at Jun. 30, 2025 1,000 193,588,410          
Balance at Dec. 31, 2025 $ 1 $ 19,416 (2,022,660) 95,111,511 899,917 (55,789,934) 38,218,251
Balance (in Shares) at Dec. 31, 2025 1,000 194,165,141          
Proceeds from Private investment in Public Equity, net of issuance costs $ 578 18,445,920 18,446,498
Proceeds from Private investment in Public Equity, net of issuance costs (in Shares) 5,774,839          
Stock-based compensation 1,934,303 1,934,303
Stock grants $ 19 1,057,390 1,057,409
Stock grants (in Shares)   191,555          
Net loss (1,550,477) (3,582,571) (5,133,048)
Balance at Mar. 31, 2026 $ 1 $ 20,013 (3,573,137) 116,549,124 899,917 (59,372,505) 54,523,413
Balance (in Shares) at Mar. 31, 2026 1,000 200,131,535          
Balance at Dec. 31, 2025 $ 1 $ 19,416 (2,022,660) 95,111,511 899,917 (55,789,934) 38,218,251
Balance (in Shares) at Dec. 31, 2025 1,000 194,165,141          
Net loss             (8,215,427)
Balance at Jun. 30, 2026 $ 1 $ 20,017 (3,994,166) 118,509,309 899,917 (62,033,855) 53,401,223
Balance (in Shares) at Jun. 30, 2026 1,000 200,169,035          
Balance at Mar. 31, 2026 $ 1 $ 20,013 (3,573,137) 116,549,124 899,917 (59,372,505) 54,523,413
Balance (in Shares) at Mar. 31, 2026 1,000 200,131,535          
Stock-based compensation 1,790,039 1,790,039
Stock issued for services $ 4 170,146 170,150
Stock issued for services (in Shares) 37,500          
Common stock issued against exercise of warrants
Conversion of notes payable to equity
Net loss (421,029) (2,661,350) (3,082,379)
Balance at Jun. 30, 2026 $ 1 $ 20,017 $ (3,994,166) $ 118,509,309 $ 899,917 $ (62,033,855) $ 53,401,223
Balance (in Shares) at Jun. 30, 2026 1,000 200,169,035